Details for New Drug Application (NDA): 214615
✉ Email this page to a colleague
The generic ingredient in TRIAMCINOLONE ACETONIDE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Summary for 214615
Tradename: | TRIAMCINOLONE ACETONIDE |
Applicant: | Apotex |
Ingredient: | triamcinolone acetonide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 214615
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 214615
Suppliers and Packaging for NDA: 214615
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | SPRAY, METERED;NASAL | 214615 | ANDA | Apotex Corp. | 60505-6275 | 60505-6275-7 | 1 BOTTLE, SPRAY in 1 CARTON (60505-6275-7) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | SPRAY, METERED;NASAL | Strength | 0.055MG/SPRAY | ||||
Approval Date: | Jan 19, 2023 | TE: | RLD: | No |
Complete Access Available with Subscription